Dexa/Me, Myself, and AI

Vaccine Development Insights

Dave shares how Moderna's platform capability allowed for rapid COVID vaccine development by leveraging existing infrastructure and algorithms. The focus on a versatile platform approach enabled quick scalability and efficient drug production.

In this clip
From this podcast
Me, Myself, and AI
AI and the COVID-19 Vaccine: Moderna’s Dave Johnson
Related Questions
- How can we speed up vaccine development?
- Can vaccine development be accelerated as discussed in the episode Biotech Revolution with Software Engineering Daily and the clip Innovative Go-to-Markets?